-
Deep Inverse Reinforcement Learning for Structural Evolution of Small Molecules
Authors:
Brighter Agyemang,
Wei-** Wu,
Daniel Addo,
Michael Y. Kpiebaareh,
Ebenezer Nanor,
Charles Roland Haruna
Abstract:
The size and quality of chemical libraries to the drug discovery pipeline are crucial for develo** new drugs or repurposing existing drugs. Existing techniques such as combinatorial organic synthesis and High-Throughput Screening usually make the process extraordinarily tough and complicated since the search space of synthetically feasible drugs is exorbitantly huge. While reinforcement learning…
▽ More
The size and quality of chemical libraries to the drug discovery pipeline are crucial for develo** new drugs or repurposing existing drugs. Existing techniques such as combinatorial organic synthesis and High-Throughput Screening usually make the process extraordinarily tough and complicated since the search space of synthetically feasible drugs is exorbitantly huge. While reinforcement learning has been mostly exploited in the literature for generating novel compounds, the requirement of designing a reward function that succinctly represents the learning objective could prove daunting in certain complex domains. Generative Adversarial Network-based methods also mostly discard the discriminator after training and could be hard to train. In this study, we propose a framework for training a compound generator and learning a transferable reward function based on the entropy maximization inverse reinforcement learning paradigm. We show from our experiments that the inverse reinforcement learning route offers a rational alternative for generating chemical compounds in domains where reward function engineering may be less appealing or impossible while data exhibiting the desired objective is readily available.
△ Less
Submitted 1 October, 2020; v1 submitted 24 July, 2020;
originally announced August 2020.
-
Multi-View Self-Attention for Interpretable Drug-Target Interaction Prediction
Authors:
Brighter Agyemang,
Wei-** Wu,
Michael Yelpengne Kpiebaareh,
Zhihua Lei,
Ebenezer Nanor,
Lei Chen
Abstract:
The drug discovery stage is a vital aspect of the drug development process and forms part of the initial stages of the development pipeline. In recent times, machine learning-based methods are actively being used to model drug-target interactions for rational drug discovery due to the successful application of these methods in other domains. In machine learning approaches, the numerical representa…
▽ More
The drug discovery stage is a vital aspect of the drug development process and forms part of the initial stages of the development pipeline. In recent times, machine learning-based methods are actively being used to model drug-target interactions for rational drug discovery due to the successful application of these methods in other domains. In machine learning approaches, the numerical representation of molecules is critical to the performance of the model. While significant progress has been made in molecular representation engineering, this has resulted in several descriptors for both targets and compounds. Also, the interpretability of model predictions is a vital feature that could have several pharmacological applications. In this study, we propose a self-attention-based multi-view representation learning approach for modeling drug-target interactions. We evaluated our approach using three benchmark kinase datasets and compared the proposed method to some baseline models. Our experimental results demonstrate the ability of our method to achieve competitive prediction performance and offer biologically plausible drug-target interaction interpretations.
△ Less
Submitted 23 August, 2020; v1 submitted 1 May, 2020;
originally announced May 2020.
-
Drug-Target Indication Prediction by Integrating End-to-End Learning and Fingerprints
Authors:
Brighter Agyemang,
Wei-** Wu,
Michael Y. Kpiebaareh,
Ebenezer Nanor
Abstract:
Computer-Aided Drug Discovery research has proven to be a promising direction in drug discovery. In recent years, Deep Learning approaches have been applied to problems in the domain such as Drug-Target Interaction Prediction and have shown improvements over traditional screening methods. An existing challenge is how to represent compound-target pairs in deep learning models. While several represe…
▽ More
Computer-Aided Drug Discovery research has proven to be a promising direction in drug discovery. In recent years, Deep Learning approaches have been applied to problems in the domain such as Drug-Target Interaction Prediction and have shown improvements over traditional screening methods. An existing challenge is how to represent compound-target pairs in deep learning models. While several representation methods exist, such descriptor schemes tend to complement one another in many instances, as reported in the literature. In this study, we propose a multi-view architecture trained adversarially to leverage this complementary behavior by integrating both differentiable and predefined molecular descriptors. We conduct experiments on clinically relevant benchmark datasets to demonstrate the potential of our approach.
△ Less
Submitted 5 December, 2019; v1 submitted 2 December, 2019;
originally announced December 2019.
